Showing results (71-80 of 303) with videos related to

Sort By:
Pageof 31
Journal of Hepatology|August 27, 2025
New targets and new drugs for hepatobiliary cancersStephen L Chan, Angela Lamarca, Chiun Hsu, et al.
Gut|May 25, 2013
Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasisKeun Hur, Paloma Cejas, Jaime Feliu, et al.
Cancer Treatment Reviews|February 9, 2016
Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?Angela Lamarca, Emma Elliott, Jorge Barriuso, et al.
Neuroendocrinology|August 23, 2019
Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid TumoursGeorge Papaxoinis, Zoe Kordatou, Lynne McCallum, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 15, 2020
The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standardLindsay E Carnie, Angela Lamarca, Mairéad G McNamara, et al.
Cancer Treatment Reviews|May 15, 2025
The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancersGiuseppe Cabibbo, Lorenza Rimassa, Angela Lamarca, et al.
Cancers|September 9, 2023
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?Héloïse Bourien, Chiara Carlotta Pircher, Boris Guiu, et al.
Expert Review of Anticancer Therapy|June 29, 2022
Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignanciesDinakshi Shah, Zainul Abedin Kapacee, Angela Lamarca, et al.
Expert Review of Molecular Diagnostics|June 27, 2025
From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncologyAlbrecht Stenzinger, Nicola Normanno, Angela Lamarca, et al.
Cancer Treatment Reviews|March 21, 2013
Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectivesAna Custodio, Jorge Barriuso, Javier de Castro, et al.
Pageof 31